Mucus D Tablet, Multilayer, Extended Release
Product Images NDC 51316-345

1 FDA label image from Cvs Woonsocket Prescription Center, Incorporated · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus D (NDC 51316-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Woonsocket Prescription Center, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cvs-mucus-d-carton-image.jpg (Cvs Mucus D Carton Image)

Cvs-mucus-d-carton-image.jpg (Cvs Mucus D Carton Image)
The packaging label for Mucus-D Maximum Strength extended-release tablets contains 1200 mg guaifenesin and 120 mg pseudoephedrine hydrochloride. The orange box features CVS branding and states the product is an expectorant and nasal decongestant in multilayer extended-release tablet form, with 24 tablets per box. The label highlights immediate and extended release lasting 12 hours, and includes drug facts, uses, warnings, directions, inactive ingredients, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.